ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Self-Sale Products	217.62M
Self-Sale Products Growth	-8.45%
Customized Products and Services	111.08M
Customized Products and Services Growth	-36.29%
Other Business	2.28M
Other Business Growth	122.65%
Trade	2.15M
Trade Growth	75.38%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
China	223.50M
China Growth	-15.64%
Foreign	109.63M
Foreign Growth	-26.60%